185 related articles for article (PubMed ID: 24803828)
1. Efficacy of ilaprazole in the treatment of duodenal ulcers: a meta-analysis.
Ji XQ; Du JF; Chen G; Chen G; Yu B
World J Gastroenterol; 2014 May; 20(17):5119-23. PubMed ID: 24803828
[TBL] [Abstract][Full Text] [Related]
2. Ilaprazole: Is this a superior proton pump inhibitor for duodenal ulcer?
Bohidar NP; Krishna K; Panda BK; Patel C
Trop Gastroenterol; 2013; 34(2):95-8. PubMed ID: 24377157
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of proton pump inhibitors for patients with duodenal ulcers: A pairwise and network meta-analysis of randomized controlled trials.
Hu ZH; Shi AM; Hu DM; Bao JJ
Saudi J Gastroenterol; 2017; 23(1):11-19. PubMed ID: 28139495
[TBL] [Abstract][Full Text] [Related]
4. Ilaprazole Compared With Rabeprazole in the Treatment of Duodenal Ulcer: A Randomized, Double-blind, Active-controlled, Multicenter Study.
Fan L; Xianghong Q; Ling W; Ying H; Jielai X; Haitang H
J Clin Gastroenterol; 2019 Oct; 53(9):641-647. PubMed ID: 30789856
[TBL] [Abstract][Full Text] [Related]
5. Randomized, parallel, double-blind comparison of the ulcer-healing effects of ilaprazole and omeprazole in the treatment of gastric and duodenal ulcers.
Ho KY; Kuan A; Zaño F; Goh KL; Mahachai V; Kim DY; Yoon HM
J Gastroenterol; 2009; 44(7):697-707. PubMed ID: 19434360
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, safety and pharmacokinetics of ilaprazole infusion in healthy subjects and patients with esomeprazole as positive control.
Wang H; Shao F; Liu X; Xu W; Ou N; Qin X; Liu F; Hou X; Hu H; Jiang J
Br J Clin Pharmacol; 2019 Nov; 85(11):2547-2558. PubMed ID: 31332820
[TBL] [Abstract][Full Text] [Related]
7. A Randomized, Double-blind, Active-Controlled, Multi-center Study of Ilaprazole in the Treatment of Reflux Esophagitis.
Xue Y; Qin X; Zhou L; Lin S; Wang L; Hu H; Xia J
Clin Drug Investig; 2016 Dec; 36(12):985-992. PubMed ID: 27605258
[TBL] [Abstract][Full Text] [Related]
8. Ilaprazole for the treatment of duodenal ulcer: a randomized, double-blind and controlled phase III trial.
Wang L; Zhou L; Hu H; Lin S; Xia J
Curr Med Res Opin; 2012 Jan; 28(1):101-9. PubMed ID: 22070512
[TBL] [Abstract][Full Text] [Related]
9. Effect of ilaprazole on the healing of endoscopic submucosal dissection-induced gastric ulcer: randomized-controlled, multicenter study.
Bang CS; Shin WG; Seo SI; Choi MH; Jang HJ; Park SW; Kae SH; Yang YJ; Shin SP; Baik GH; Kim HY
Surg Endosc; 2019 May; 33(5):1376-1385. PubMed ID: 30167954
[TBL] [Abstract][Full Text] [Related]
10. Modeling the cost-effectiveness of ilaprazole versus omeprazole for the treatment of newly diagnosed duodenal ulcer patients in China.
Xuan JW; Song RL; Xu GX; Lu WQ; Lu YJ; Liu Z
J Med Econ; 2016 Nov; 19(11):1056-1060. PubMed ID: 27223846
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the effect of ilaprazole on intragastric pH in patients with duodenal ulcer].
Zhou LY; Lin SR; Yang YS; Zhang ST; Yuan YZ; Shi RH; Hou XH; Xia JL; Hu HT; Qin XH
Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):290-2. PubMed ID: 20627032
[TBL] [Abstract][Full Text] [Related]
12. A new PPI, ilaprazole compared with omeprazole in the treatment of duodenal ulcer: a randomized double-blind multicenter trial.
Wang L; Zhou L; Lin S; Hu H; Xia J
J Clin Gastroenterol; 2011 Apr; 45(4):322-9. PubMed ID: 20679904
[TBL] [Abstract][Full Text] [Related]
13. Ilaprazole for the treatment of gastro-esophageal reflux.
Savarino E; Ottonello A; Martinucci I; Dulbecco P; Savarino V
Expert Opin Pharmacother; 2016 Oct; 17(15):2107-13. PubMed ID: 27598861
[TBL] [Abstract][Full Text] [Related]
14. The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment.
de Bortoli N; Martinucci I; Giacchino M; Blandizzi C; Marchi S; Savarino V; Savarino E
Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1361-9. PubMed ID: 23802731
[TBL] [Abstract][Full Text] [Related]
15. Effects of 3-day IV pantoprazole versus omeprazole on 24-hour intragastric acidity at 3 days in Chinese patients with duodenal ulcer: A single-center, prospective, randomized, comparative, pilot trial.
Lin HJ; Lo WC; Cheng YC; Perng CL
Clin Ther; 2006 Sep; 28(9):1303-7. PubMed ID: 17062303
[TBL] [Abstract][Full Text] [Related]
16. [Ilaprazole based bismuth-containing quadruple regimen for the first-line treatment of Helicobacter pylori infection: a multicenter, randomized, controlled clinical study].
Gao W; Cheng H; Hu FL; Lü NH; Xie Y; Sheng JQ; Xu JM; Zhang LX; Zhang L; Chen Y; Zhang ZY; Zhang GX; Cui MH; Yang GB; Gao HJ; Yang L
Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(30):2108-12. PubMed ID: 23158273
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries.
Mo C; Sun G; Lu ML; Zhang L; Wang YZ; Sun X; Yang YS
World J Gastroenterol; 2015 May; 21(17):5382-92. PubMed ID: 25954113
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics, pharmacodynamics and safety of oral doses of ilaprazole 10, 20 and 40 mg and esomeprazole 40 mg in healthy subjects: a randomised, open-label crossover study.
Shin JS; Lee JY; Cho KH; Park HL; Kukulka M; Wu JT; Kim DY; Park SH
Aliment Pharmacol Ther; 2014 Sep; 40(5):548-61. PubMed ID: 25041486
[TBL] [Abstract][Full Text] [Related]
19. Standard-Dose Proton Pump Inhibitors in the Initial Non-eradication Treatment of Duodenal Ulcer: Systematic Review, Network Meta-Analysis, and Cost-Effectiveness Analysis.
Zhang J; Ge L; Hill M; Liang Y; Xie J; Cui D; Li X; Zheng W; He R
Front Pharmacol; 2018; 9():1512. PubMed ID: 30666204
[No Abstract] [Full Text] [Related]
20. Prevention of NSAID-induced gastroduodenal ulcers.
Rostom A; Dube C; Wells G; Tugwell P; Welch V; Jolicoeur E; McGowan J
Cochrane Database Syst Rev; 2002; (4):CD002296. PubMed ID: 12519573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
